"It appears that the defendant has kept the pack of the plaintiff in front while preparing its pack," the court said.

Roche's bid to block a generic SMA drug risks public health by limiting affordable access, say patient groups, highlighting high costs and patent issues.

Public health groups are challenging Roche's attempt to block a generic version of its expensive Spinal Muscular Atrophy drug ...

Roche, a Swiss multinational healthcare company, is seeking a permanent injunction against Natco Pharma to prevent the introduction of a generic version of Risdiplam, a Spinal Muscular Atrophy (SMA) ...

The company, which processes food waste into animal feed, is facing a lawsuit from the attorney general's office.

Lyft Inc. has agreed to pay $2.1 million in civil penalties to resolve allegations of making false and misleading statements ...

Clear geographic boundaries in a statutory injunction gave police much-needed power to enforce bylaws during Freedom Convey ...

Health groups and patient advocates are raising concerns over patent monopolies on rare disease drugs in India. They argue ...

Health groups and patients calls for government interference to make rare disease drugs affordable: Our Bureau, New Delhi Tuesday, November 5, 2024, 18:10 Hrs [IST] Health groups ...